Publikationer 2015

Ahlstrand I, Thyberg I, Falkmer T, Dahlström Ö, Björk M , Pain and activity limitations in women and men with contemporary treated early RA compared to 10 years ago: the Swedish TIRA project, Scand J Rheumatol. 2015; 44(4):259-64

Andersson ML, Forslind K, Hafström I , Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis – A BARFOT Study, Open Rheumatol J. 2015 Feb 3;9:8-15

Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Ho M, Holmqvist M, Horne L, Inoue E, Michaud K, Nyberg F, Pappas DA, Reed G, Tanaka E, Tran TN, Verstappen SM, Yamanaka H, Wesby-van Swaay E, Symmons D, How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries. Ann Rheum Dis. 2015 Nov. 30.

Chatzidionysiou K, Kristensen LE, Eriksson J, Askling J, van Vollenhoven R, For the Artis Group., Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register. Scand J Rheumatol. 2015 Nov; 44(6):431-7

Di Giuseppe D, Bottai M, Askling J, Wolk A., Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study, Arthritis Res Ther. 2015 Mar 4; 17:40.

Eriksson JK, Johansson K, Askling J, Neovius M,Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed? Ann Rheum Dis. 2015 Apr; 74(4):648-54

Eriksson JK, Karlsson JA, Bratt J, Petersson IF, van Vollenhoven RF, Ernestam S, Geborek P, Neovius M,Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial. Ann Rheum Dis. 2015 Jun; 74(6):1094-101

Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d’Elia H, Turesson C, Kristensen LE, Jacobsson LT., Mortality in ankylosing spondylitis: results from a nationwide population-based study, Ann Rheum Dis. 2015 Sep 2

Geijer M, Lindqvist U, Husmark T, Alenius GM, Larsson PT, Teleman A, Theander E ,The Swedish Early Psoriatic Arthritis Registry 5-year Followup: Substantial Radiographic Progression Mainly in Men with High Disease Activity and Development of Dactylitis, J Rheumatol. 2015 Nov; 42(11):2110-7

Fernandes-Cerqueira C, Ossipova E, Gunasekera S, Hansson M, Mathsson L, Catrina AI, Sommarin Y, Klareskog L, Lundberg K, Rönnelid J, Göransson U, Jakobsson PJ,Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens. Arthritis Res Ther. 2015 Jun 10; 17:155

Forsblad-d’Elia H, Bengtsson K, Kristensen LE, Jacobsson LT. , Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register, Rheumatology (Oxford). 2015 Jul; 54(7):1186-93
Frisell T, Saevarsdottir S, Askling J, Does a family history of RA influence the clinical presentation and treatment response in RA? Ann Rheum Dis. 2015 Jun 19.

Jakobsson GL, Stephansson O, Askling J, Jacobsson LT, Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study. Ann Rheum Dis. 2015 Dec 23.

Jiang X, Frisell T, Askling J, Karlson EW, Klareskog L, Alfredsson L, Källberg H, To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors? Arthritis Rheumatol. 2015 Feb; 67(2):352-62

Jiang X, Sandberg ME, Saevarsdottir S, Klareskog L, Alfredsson L, Bengtsson C., Higher education is associated with a better rheumatoid arthritis outcome concerning for pain and function but not disease activity: results from the EIRA cohort and Swedish rheumatology register. Arthritis Res Ther. 2015 Nov 6; 17:317.

Johansson K, Eriksson JK, van Vollenhoven R, Miller H, Askling J, Neovius M; ARTIS Study Group., Does disease activity at the start of biologic therapy influence health care costs in patients with RA? Rheumatology (Oxford). 2015 Aug; 54(8):1472-7.

Kalkan A, Husberg M, Hallert E, Roback K, Thyberg I, Skogh T, Carlsson P.,Physician preferences and variations in prescription of biological drugs for rheumatoid arthritis – a register-based study of 4010 patients in Sweden. Arthritis Care Res (Hoboken). 2015 Jun 19

Kearsley-Fleet L, Závada J, Hetland ML, Nordström DC, Aaltonen KJ, Listing J, Zink A, Gati T, Rojkovich B, Iannone F, Gremese E, van Riel PL, van de Laar MA, Lie E, Kvien TK, Canhão H, Fonseca JE, Rotar Ž, Loza E, Carmona L, Askling J, Johansson K, Finckh A, Dixon WG, Hyrich KL; EULAR Study Group for Registers and Observational Drug Studies ,The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers, Rheumatology (Oxford). 2015 Jun; 54(6):1074-9

Kim K, Jiang X, Cui J, Lu B, Costenbader KH, Sparks JA, Bang SY, Lee HS, Okada Y, Raychaudhuri S, Alfredsson L, Bae SC, Klareskog L, Karlson EW, Interactions between amino acid-defined major histocompatibility complex class II variants and smoking in seropositive rheumatoid arthritis. Arthritis Rheumatol. 2015 Oct;67(10):2611-23

Lie E, Kristensen LE, Forsblad-d’Elia H, Zverkova-Sandström T, Askling J, Jacobsson LT; ARTIS Study Group, The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study. Ann Rheum Dis. 2015 Jun;74(6):970-8

Levay, C, Policies to foster quality improvement registries: lessons from the Swedish case. J Intern Med. 2015 Oct 5.

Levitsky A, Erlandsson MC, van Vollenhoven RF, Bokarewa MI, Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial. BMC Med. 2015 Sep 30;13:247

Levitsky A, Forslind K, van Vollenhoven RF; SWEFOT trial group, Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial, Scand J Rheumatol. 2015; 44(5):348-53

Mantel Ä, Holmqvist M, Nyberg F, Tornling G, Frisell T, Alfredsson L, Askling J, Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New-Onset Rheumatoid Arthritis: A Nested Case-Control Study. Arthritis Rheumatol. 2015 Nov; 67(11):2845-54

Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S, Patient reported outcome measures in practice, BMJ. 2015 Feb 10; 350:g7818. Abstrakt finns inte.

Nyberg F, Askling J, Berglind N, Franzén S, Ho M, Holmqvist M, Horne L, Lampl K, Michaud K, Pappas DA, Reed G, Symmons D, Tanaka E, Tran TN, Verstappen SM, Wesby-van Swaay E, Yamanaka H, Greenberg JD, Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach. Pharmacoepidemiol Drug Saf. 2015 Nov; 24(11):1121-32

Olofsson T, Johansson K, Eriksson JK, van Vollenhoven R, Miller H, Petersson IF, Askling J, Neovius M, Does disease activity at start of biologic therapy influence work-loss in RA patients? Rheumatology (Oxford). 2015 Dec 18

Orellana C, Saevarsdottir S, Klareskog L, Karlson EW, Alfredsson L, Bengtsson C , Postmenopausal hormone therapy and the risk of rheumatoid arthritis: results from the Swedish EIRA population-based case-control study. Eur J Epidemiol. 2015 May; 30(5):449-57.

Pikwer M, Orellana C, Källberg H, Pikwer A, Turesson C, Klareskog L, Alfredsson L, Saevarsdottir S, Bengtsson C., Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material. Arthritis Res Ther. 2015 Dec 12; 17:358.

Radner H, Dixon W, Hyrich K, Askling J, Consistency and utility of data items across European rheumatoid arthritis clinical cohorts and registers, Arthritis Care Res (Hoboken). 2015 Apr 17

Sandberg ME, Bengtsson C, Klareskog L, Alfredsson L, Saevarsdottir S , Recent infections are associated with decreased risk of rheumatoid arthritis: a population-based case-control study. Ann Rheum Dis. 2015 May; 74(5):904-7
Simard JF, Ekberg S, Johansson AL, Askling J.,What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer. Ann Rheum Dis. 2015 May 6.

Sverker A, Östlund G, Thyberg M, Thyberg I, Valtersson E, Björk M, Dilemmas of participation in everyday life in early rheumatoid arthritis: a qualitative interview study (The Swedish TIRA Project). Disabil Rehabil. 2015; 37(14):1251-9.

Wadström H, Frisell T, Sparén P, Askling J; ARTIS study group , Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden. Ann Rheum Dis. 2016 Jan 11

Wadström H, Eriksson JK, Neovius M, Askling J; ARTIS Study Group, How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? Scand J Rheumatol. 2015; 44(1):22-8

van Heemst J, Hensvold AH, Jiang X, van Steenbergen H, Klareskog L, Huizinga TW, van der Helm-van Mil A, Catrina AI, Toes RE, Lundberg K, van der Woude D. , Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA, Ann Rheum Dis. 2015 Dec 29

Verstappen SM, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg JD, Holmqvist M, Horne L, Lampl K, Michaud K, Nyberg F, Pappas DA, Reed G, Symmons DP, Tanaka E, Tran TN, Yamanaka H, Ho M., Methodological challenges when comparing demographic and clinical characteristics of international observational registries. Arthritis Care Res (Hoboken). 2015 Jul 20

Östlund G, Björk M, Valtersson E, Sverker A ,Lived Experiences of Sex Life Difficulties in Men and Women with Early RA – The Swedish TIRA Project, Musculoskeletal Care. 2015 Jun 5